AGEN
AGENUS INC
NASDAQ · Healthcare · Biotechnology · US
$7.85
+8.73%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.02
- Revenue estimate
- $28.2M
Latest reported
- Last report date
- Sep 10, 2026
- EPS actual
- -$0.01
- EPS estimate
- $0.04
- Revenue actual
- $34.5M
- Revenue estimate
- $34.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -1.6%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $26
- PT range
- $14 – $40
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 10, 2026 | $0.04 | -$0.01 | Miss -122.22% | $34.5M |
| May 11, 2026 | $2.10 | $1.02 | Miss -51.43% | $33.7M |
| Mar 16, 2026 | -$1.04 | $0.56 | Beat 153.67% | $34.2M |
| Mar 11, 2025 | -$2.36 | -$2.04 | Beat 13.56% | $26.8M |
| Aug 8, 2024 | -$1.44 | -$2.52 | Miss -75.00% | $23.5M |
| Mar 14, 2024 | -$0.40 | -$2.60 | Miss -550.00% | $83.8M |
| Mar 14, 2023 | -$4.40 | -$4.80 | Miss -9.09% | $28.4M |
| Aug 9, 2022 | -$4.60 | -$3.40 | Beat 26.09% | $20.9M |
| Mar 1, 2022 | -$3.20 | -$5.20 | Miss -62.50% | $20.3M |
| May 6, 2021 | -$6.20 | -$5.40 | Beat 12.90% | $11.7M |
| Mar 15, 2021 | -$4.40 | -$4.00 | Beat 9.09% | $31.3M |
| Oct 29, 2020 | -$5.20 | -$5.60 | Miss -7.69% | $14.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026